Creso Pharma’s subsidiary has had a huge win in Canada.
The post Here’s why the Creso Pharma (ASX:CPH) share price is up 8% today appeared first on The Motley Fool Australia. –
The Creso Pharma Ltd (ASX: CPH) share price is having a fantastic day on the ASX.
The company’s shares are soaring after it announced its subsidiary, Mernova, has been granted a medical cannabis licence in Canada. Mernova has also received a number of new purchase orders.
Right now, the Creso Pharma share price is 8% higher than its previous close. Shares in the company are swapping hands for 14 cents apiece.
Let’s take a closer look at today’s news from the pharmaceutical cannabis producer.
News from Mernova
The Creso Pharma share price is gaining today following news of Mernova’s new sales licence.
Mernova can now sell medicinal cannabis products directly to customers.
In the past, Health Canada had only allowed the company to sell its medicinal products through wholesalers. Although, it was able to sell directly to recreational cannabis users.
Creso Pharma said that CA$500 million was spent on medicinal cannabis products in Canada in 2019.
The company also believes Mernova’s new licence could create a recurring revenue stream.
The Creso Pharma share price is also likely being driven by news of purchase orders.
Mernova has recently received CA$224,580 ($242,546) worth of purchase orders for products under its Ritual Green and Ritual Sticks brands.
Mernova said the purchase orders highlight increasing demand for its recreational products.
Commentary from management
Mernova’s managing director, Jack Yu, commented on the news from Creso Pharma today:
The direct-to-patient medicinal market has the potential to be huge for us. It increases our distribution channels from four provinces and territories to nation-wide, and allows for direct-to-patient sales, which provides us with increased control over pricing, as well as direct interaction with, and feedback from, valued customers…
Purchase orders for recreational sales continue to grow steadily, and we anticipate increased growth with the introduction of new strains and additional products, in the coming months.
Creso Pharma share price snapshot
Today’s gains aren’t enough to get the Creso Pharma share price back into the green.
The company’s shares are currently trading for 25% less than they were at the start of 2021. However, they have gained 237% since this time last year.
The company has a market capitalisation of around $149 million, with approximately 1.2 billion shares outstanding.
Should you invest $1,000 in Creso Pharma right now?
Before you consider Creso Pharma, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Creso Pharma wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of May 24th 2021
Here’s why the Creso Pharma (ASX:CPH) share price is up 7%
Why the Creso Pharma (ASX:CPH) share price is soaring 9% higher today
Here’s why the Creso Pharma (ASX:CPH) share price is surging 15% higher
Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.
The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.